Furiex Pharmaceuticals (FURX) Narrows Q3 Loss
Tweet
Share
E-mailGet Alerts FURX Hot Sheet
Join SI Premium – FREE
Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) reported Q3 loss of ($1.32), versus ($2.14) reported last year. Revenue for the quarter came in at $1.27 million, versus $288 thousand reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Western Digital (WDC) Tops Q3 EPS by 42c; offers guidance
- Terex (TEX) Tops Q1 EPS by 24c, provides guidance
- Edwards Lifesciences (EW) Tops Q1 EPS by 2c; offers guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
